Doug Evans
President & CEO, Lungpacer Medical
Doug Evans, PE, President & CEO of Lungpacer Medical Inc., is an accomplished medical device executive, business leader, and strategist with 30 years of industry, public, and private company experience. He is a serial innovator of first-of-their-kind products and has over 200 issued patents covering dozens of devices used by over 15 million patients worldwide, generating greater than $4 billion in end-user sales.
Doug serves as Chairman for TELA Bio (NASDAQ: TELA) and Board Member for WhiteSwell Medical. Previously Doug served as Operating Director, Secretary, and Board Member of Intact Vascular (acquired by Royal Philips for $360M in 2020); as advisor to Essential Medical (acquired by Teleflex in 2018); and as Chief Operating Officer and Board Member of Kensey Nash Corporation (NASDAQ: KNSY) (acquired by Royal DSM for $360M in 2012).
Doug serves as Chairman for TELA Bio (NASDAQ: TELA) and Board Member for WhiteSwell Medical. Previously Doug served as Operating Director, Secretary, and Board Member of Intact Vascular (acquired by Royal Philips for $360M in 2020); as advisor to Essential Medical (acquired by Teleflex in 2018); and as Chief Operating Officer and Board Member of Kensey Nash Corporation (NASDAQ: KNSY) (acquired by Royal DSM for $360M in 2012).
Doug has a Bachelors in Engineering Science, an honors degree in Bioengineering, and a Masters in Business Management from Pennsylvania State University, as well as a Masters in Electrical Engineering from University of Pennsylvania.
Doug is the co-founder of Cure4Cam Childhood Cancer Foundation, which seeks to raise community awareness about childhood cancers and supports the development of new and more humane therapies for children.
